Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Tangible Net Worth Ratio

Latest as of March 2026: 85.7%

Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Tangible Net Worth Ratio of 85.7% as of March 2026. This metric is calculated by deducting intangible assets (CN¥314.20 Million) from net assets (CN¥2.20 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Anhui Fengyuan Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

85.7%
Tangible equity / total equity

Net Assets (Equity)

CN¥2.20 Billion
CNY

Intangible Assets

CN¥314.20 Million
Goodwill, patents, brand value

Total Assets

CN¥5.37 Billion
CNY

Anhui Fengyuan Pharmaceutical Co Ltd Tangible Net Worth Ratio (1997–2025)

This chart shows how Anhui Fengyuan Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of March 2026, the ratio stands at 85.7%, reflecting net assets of CN¥2.20 Billion with intangible assets of CN¥314.20 Million CNY. See Anhui Fengyuan Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Anhui Fengyuan Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for Anhui Fengyuan Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Anhui Fengyuan Pharmaceutical Co Ltd stock valuation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 85.5% CN¥2.13 Billion CN¥308.26 Million CN¥5.06 Billion ▲ +0.0 pp
2024 85.5% CN¥2.05 Billion CN¥296.73 Million CN¥4.70 Billion ▲ +0.4 pp
2023 85.1% CN¥1.92 Billion CN¥285.63 Million CN¥4.39 Billion ▼ -0.9 pp
2022 86.0% CN¥1.75 Billion CN¥244.87 Million CN¥4.47 Billion ▲ +0.5 pp
2021 85.5% CN¥1.56 Billion CN¥225.80 Million CN¥3.82 Billion ▼ -0.1 pp
2020 85.6% CN¥1.45 Billion CN¥208.75 Million CN¥3.64 Billion ▼ -1.5 pp
2019 87.1% CN¥1.33 Billion CN¥171.32 Million CN¥3.56 Billion ▼ 0.0 pp
2018 87.1% CN¥1.29 Billion CN¥166.46 Million CN¥3.01 Billion ▼ -1.7 pp
2017 88.8% CN¥1.22 Billion CN¥136.24 Million CN¥2.77 Billion ▲ +0.9 pp
2016 88.0% CN¥1.15 Billion CN¥138.53 Million CN¥2.49 Billion ▲ +2.9 pp
2015 85.0% CN¥1.18 Billion CN¥177.07 Million CN¥2.31 Billion ▲ +0.3 pp
2014 84.8% CN¥1.15 Billion CN¥174.64 Million CN¥2.24 Billion ▲ +1.1 pp
2013 83.7% CN¥1.05 Billion CN¥172.15 Million CN¥1.98 Billion ▲ +5.4 pp
2012 78.3% CN¥775.01 Million CN¥168.22 Million CN¥1.45 Billion ▼ -0.1 pp
2011 78.4% CN¥765.24 Million CN¥165.21 Million CN¥1.32 Billion ▼ -1.9 pp
2010 80.4% CN¥753.81 Million CN¥148.11 Million CN¥1.28 Billion ▼ -9.7 pp
2009 90.0% CN¥678.70 Million CN¥67.77 Million CN¥1.21 Billion ▲ +0.6 pp
2008 89.4% CN¥654.09 Million CN¥69.37 Million CN¥1.17 Billion ▲ +0.3 pp
2007 89.1% CN¥638.89 Million CN¥69.36 Million CN¥1.09 Billion ▼ -8.3 pp
2006 97.5% CN¥620.49 Million CN¥15.73 Million CN¥1.07 Billion ▲ +0.8 pp
2005 96.7% CN¥599.59 Million CN¥19.86 Million CN¥1.09 Billion ▲ +0.6 pp
2004 96.1% CN¥591.07 Million CN¥23.05 Million CN¥895.92 Million ▲ +0.4 pp
2003 95.7% CN¥576.00 Million CN¥24.65 Million CN¥736.92 Million ▲ +0.5 pp
2002 95.2% CN¥560.87 Million CN¥27.03 Million CN¥684.42 Million ▼ -3.3 pp
2001 98.4% CN¥536.15 Million CN¥8.40 Million CN¥709.48 Million ▼ -1.5 pp
2000 99.9% CN¥532.50 Million CN¥320.00K CN¥634.79 Million ▲ +0.2 pp
1999 99.7% CN¥52.98 Million CN¥160.00K CN¥134.63 Million ▼ -0.3 pp
1998 100.0% CN¥44.35 Million CN¥0.00 CN¥110.33 Million ▲ +0.1 pp
1997 99.9% CN¥24.03 Million CN¥12.76K CN¥58.92 Million
pp = percentage points